Taken together, our results from the nationwide epidemiological analysis and comparison of the disease phenotype in mice with Blimp-1 deficiency-mediated colitis between two genetic backgrounds indicate a higher prevalence of CD in people with T1D and an autoimmune diabetes-prone background-mediated promotion of colitogenesis. This evidence concerns the gene PRDM1 and colitis.